Updated: April 9, 2026
Sandostatin Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Summarize with AI
- Major Interaction: Lutetium Lu 177 Dotatate (Lutathera)
- Major Interaction: Cyclosporine (Transplant Rejection Risk)
- Moderate Interaction: Insulin and Antidiabetic Medications
- Moderate Interaction: CYP3A4 Metabolized Drugs (Quinidine, Terfenadine)
- Minor Interaction: Bromocriptine
- Drug-Food Interaction: Total Parenteral Nutrition (TPN)
- What to Tell Your Doctor and Pharmacist
- Monitoring Recommended While on Sandostatin
Sandostatin (octreotide) interacts with several medications — including cyclosporine, lutetium Lu 177 dotatate, and insulin. Here's what you need to know and tell your doctor.
Sandostatin (octreotide) works by suppressing multiple hormones and altering how various body systems function. Because it affects hormone levels, blood sugar, bile secretion, and drug metabolism, it has the potential to interact with several types of medications. Knowing about these interactions — and making sure your doctor and pharmacist have a complete list of everything you take — is essential to your safety.
Major Interaction: Lutetium Lu 177 Dotatate (Lutathera)
If you have a gastroenteropancreatic neuroendocrine tumor (GEP-NET) and your doctor is considering or has started peptide receptor radionuclide therapy (PRRT) with lutetium Lu 177 dotatate (Lutathera), you need to know about this critical interaction.
Octreotide and lutetium Lu 177 dotatate both bind to somatostatin receptors on tumor cells. When taken at the same time, octreotide competes with lutetium dotatate for receptor binding, which can reduce the effectiveness of the PRRT treatment.
FDA labeling requires that Sandostatin Injection be discontinued at least 24 hours before each lutetium Lu 177 dotatate dose. For patients on Sandostatin LAR Depot, a transition to short-acting octreotide injection is needed before initiating Lutathera treatment, so the timing can be managed around each treatment cycle. Never adjust these treatments on your own — your oncologist will manage the timing.
Major Interaction: Cyclosporine (Transplant Rejection Risk)
Octreotide has been shown to decrease blood levels of cyclosporine — an immunosuppressant medication critical for preventing organ transplant rejection. If cyclosporine levels fall too low, the transplanted organ may be rejected.
If you've had an organ transplant and are on cyclosporine, tell your doctor before starting Sandostatin. Cyclosporine blood levels will need to be closely monitored and the dose may need adjustment.
Moderate Interaction: Insulin and Antidiabetic Medications
Sandostatin suppresses both insulin and glucagon — the two hormones that regulate blood sugar. This means blood sugar can swing in either direction (too high or too low) while taking octreotide.
If you take insulin, metformin, sulfonylureas, or other antidiabetic medications, Sandostatin can alter their effectiveness. Your dose may need to be adjusted — up or down — when starting Sandostatin or changing doses. Blood glucose monitoring is recommended at baseline and when doses are changed.
Signs of low blood sugar: headache, hunger, sweating, shakiness, dizziness, fast heartbeat. Signs of high blood sugar: increased thirst, frequent urination, dry mouth, blurry vision.
Moderate Interaction: CYP3A4 Metabolized Drugs (Quinidine, Terfenadine)
Octreotide suppresses growth hormone secretion, and growth hormone plays a role in regulating how the liver metabolizes certain drugs through the CYP3A4 enzyme pathway. By suppressing GH, octreotide may decrease the clearance of drugs metabolized by CYP3A4 — meaning those drugs could accumulate to higher-than-expected levels in your blood.
Drugs with a narrow therapeutic index that are metabolized by CYP3A4 require particular caution. Examples include:
- Quinidine (antiarrhythmic)
- Terfenadine (antihistamine, largely discontinued)
- Other CYP3A4 substrates with narrow therapeutic windows should be used with caution and monitored.
Minor Interaction: Bromocriptine
Octreotide may increase the bioavailability (absorption and availability) of bromocriptine, a dopamine agonist sometimes used for acromegaly or Parkinson's disease. This interaction is generally mild, but your doctor should be aware of it if you're on both medications.
Drug-Food Interaction: Total Parenteral Nutrition (TPN)
Sandostatin Injection is not compatible with Total Parenteral Nutrition (TPN) solutions because it forms a glycosyl octreotide conjugate that reduces the drug's efficacy. If you need TPN, Sandostatin should be administered separately, not mixed in the same infusion bag.
What to Tell Your Doctor and Pharmacist
Before starting Sandostatin, make sure your doctor and pharmacist know about all medications, supplements, and vitamins you're taking. Pay particular attention to flagging:
- All diabetes medications (insulin, metformin, sulfonylureas, GLP-1 agonists, SGLT2 inhibitors)
- Immunosuppressants, especially cyclosporine or tacrolimus (for organ transplant)
- Any heart rhythm medications (antiarrhythmics)
- Any planned or current peptide receptor radionuclide therapy (PRRT) with lutetium Lu 177 dotatate
- Any medications with a narrow therapeutic window that are metabolized by the liver
Monitoring Recommended While on Sandostatin
Your doctor should monitor the following while you're on Sandostatin:
- Blood glucose levels (at baseline and when doses change)
- Thyroid function (TSH and free T4) — at baseline and periodically
- Gallbladder (ultrasound) — periodically for long-term use
- Vitamin B12 levels — periodically during long-term treatment
- Cardiac monitoring if receiving Sandostatin intravenously
For a full overview of what to watch for, read our guide on Sandostatin side effects. And if you're having trouble locating your Sandostatin prescription at a pharmacy, medfinder can help.
Frequently Asked Questions
Yes, but with careful monitoring. Sandostatin suppresses both insulin and glucagon, which can cause blood sugar to swing high or low. If you're on insulin or other antidiabetic medications, your doses may need to be adjusted. Blood glucose monitoring is recommended when starting Sandostatin and when doses change. Do not adjust your insulin or antidiabetic doses without guidance from your doctor.
Yes — this is a critical interaction. Octreotide competes with lutetium Lu 177 dotatate for somatostatin receptor binding, reducing the efficacy of PRRT therapy. Sandostatin Injection must be discontinued at least 24 hours before each Lutathera dose. Patients on Sandostatin LAR Depot need to transition to short-acting octreotide so the timing can be managed around each treatment cycle. Your oncologist will coordinate this.
Yes. Sandostatin decreases blood levels of cyclosporine, an immunosuppressant critical for transplant patients. Lower cyclosporine levels can lead to organ rejection. If you've had an organ transplant, your doctor must monitor your cyclosporine levels closely when starting or changing Sandostatin doses, and adjust the cyclosporine dose as needed.
There are no known direct food-drug interactions with Sandostatin. However, Sandostatin can impair fat absorption (steatorrhea), so patients on long-term octreotide may benefit from a low-fat diet or pancreatic enzyme supplementation. The immediate-release injection is sometimes timed between meals to reduce GI side effects. Ask your doctor if any dietary modifications are recommended for your specific situation.
Yes. Sandostatin suppresses multiple hormones: growth hormone, IGF-1, insulin, glucagon, TSH (leading to potential hypothyroidism), gastrin, VIP, secretin, serotonin, motilin, and others. This broad hormonal suppression is both the source of its therapeutic benefit and the reason for its wide range of potential side effects. Your doctor should monitor thyroid function and glucose levels during treatment.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Sandostatin also looked for:
More about Sandostatin
33,257 have already found their meds with Medfinder.
Start your search today.





